Truist Financial restated their buy rating on shares of Caribou Biosciences (NASDAQ:CRBU – Free Report) in a report published on Thursday, Benzinga reports. Truist Financial currently has a $19.00 price target on the stock. Separately, HC Wainwright reaffirmed a buy rating and issued a $24.00 price target on shares of Caribou Biosciences in a research […]
Caribou Biosciences (NASDAQ:CRBU – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at Truist Financial in a research note issued to investors on Thursday, Benzinga reports. They presently have a $19.00 target price on the stock. Truist Financial’s target price indicates a potential upside of 426.32% from the stock’s current price. […]
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Sold by E Fund Management Co. Ltd. dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
abrdn plc purchased a new stake in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 181,487 shares of the company’s stock, valued at approximately $1,040,000. Several other institutional investors have also added to or reduced their stakes […]
Caribou Biosciences, Inc. (NASDAQ:CRBU – Get Free Report)’s share price traded up 6.5% during trading on Monday . The stock traded as high as $5.59 and last traded at $5.57. 298,268 shares were traded during mid-day trading, a decline of 82% from the average session volume of 1,614,575 shares. The stock had previously closed at […]